Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 3
2015 2
2016 1
2017 4
2018 7
2019 5
2020 12
2021 7
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Androgen receptor in breast cancer: The "5W" questions.
Ravaioli S, Maltoni R, Pasculli B, Parrella P, Giudetti AM, Vergara D, Tumedei MM, Pirini F, Bravaccini S. Ravaioli S, et al. Among authors: tumedei mm. Front Endocrinol (Lausanne). 2022 Aug 30;13:977331. doi: 10.3389/fendo.2022.977331. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36111296 Free PMC article. Review.
Are we ready to use TMB in breast cancer clinical practice?
Ravaioli S, Limarzi F, Tumedei MM, Palleschi M, Maltoni R, Bravaccini S. Ravaioli S, et al. Among authors: tumedei mm. Cancer Immunol Immunother. 2020 Oct;69(10):1943-1945. doi: 10.1007/s00262-020-02682-w. Epub 2020 Jul 28. Cancer Immunol Immunother. 2020. PMID: 32725361
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter.
Bravaccini S, Ravaioli S, Tumedei MM, Rocca A, Palleschi M, Puccetti M, Parrella P, Altini M, Maltoni R. Bravaccini S, et al. Among authors: tumedei mm. Clin Cancer Res. 2020 Jul 15;26(14):3892-3893. doi: 10.1158/1078-0432.CCR-20-0668. Clin Cancer Res. 2020. PMID: 32669274 No abstract available.
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival.
Tumedei MM, Piccinini F, Azzali I, Pirini F, Bravaccini S, De Matteis S, Agostinelli C, Castellani G, Zanoni M, Cortesi M, Vergani B, Leone BE, Righi S, Gazzola A, Casadei B, Gentilini D, Calzari L, Limarzi F, Sabattini E, Pession A, Tazzari M, Bertuzzi C. Tumedei MM, et al. Int J Mol Sci. 2023 Jun 8;24(12):9909. doi: 10.3390/ijms24129909. Int J Mol Sci. 2023. PMID: 37373066 Free PMC article.
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer.
Cortesi M, Zanoni M, Maltoni R, Ravaioli S, Tumedei MM, Pirini F, Bravaccini S. Cortesi M, et al. Among authors: tumedei mm. Expert Opin Ther Targets. 2022 Jul;26(7):593-602. doi: 10.1080/14728222.2022.2113513. Epub 2022 Aug 19. Expert Opin Ther Targets. 2022. PMID: 35962580
Explaining the aggressiveness of breast cancer in sub-Saharan African patients.
Bravaccini S, Bucchi L, Puccetti M, Ravaioli S, Tumedei MM, Serra P, Masini C, Kahima J, Masalu N, Amadori D. Bravaccini S, et al. Among authors: tumedei mm. J Clin Pathol. 2019 Oct;72(10):723-724. doi: 10.1136/jclinpath-2019-206071. Epub 2019 Aug 13. J Clin Pathol. 2019. PMID: 31409610 No abstract available.
Why the complications of COVID-19 patients differ in elderly and young cancer patients.
Bravaccini S, Nicolini F, Zanoni M, Gaimari A, Cerchione C, Maltoni R, Pirini F, Mazzotti L, Cortesi M, Ravaioli S, Tumedei MM, Mazza M. Bravaccini S, et al. Among authors: tumedei mm. Transl Oncol. 2022 Dec;26:101541. doi: 10.1016/j.tranon.2022.101541. Epub 2022 Sep 12. Transl Oncol. 2022. PMID: 36119944 Free PMC article.
Spotlight on PSMA as a new theranostic biomarker for bladder cancer.
Tumedei MM, Ravaioli S, Matteucci F, Celli M, De Giorgi U, Gunelli R, Puccetti M, Paganelli G, Bravaccini S. Tumedei MM, et al. Sci Rep. 2021 May 7;11(1):9777. doi: 10.1038/s41598-021-89160-0. Sci Rep. 2021. PMID: 33963223 Free PMC article.
44 results